Thomas M. Grogan

25.4k total citations · 2 hit papers
160 papers, 9.2k citations indexed

About

Thomas M. Grogan is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Thomas M. Grogan has authored 160 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 71 papers in Pathology and Forensic Medicine and 48 papers in Molecular Biology. Recurrent topics in Thomas M. Grogan's work include Lymphoma Diagnosis and Treatment (66 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Thomas M. Grogan is often cited by papers focused on Lymphoma Diagnosis and Treatment (66 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Thomas M. Grogan collaborates with scholars based in United States, Canada and Spain. Thomas M. Grogan's co-authors include Thomas P. Miller, Catherine Spier, William Bellamy, Y Frutiger, William S. Dalton, TP Miller, L Richter, Richard I. Fisher, Michael LeBlanc and Roger A. Warnke and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Thomas M. Grogan

154 papers receiving 8.8k citations

Hit Papers

Chemotherapy Alone Compared with Chemotherapy plus Radiot... 1989 2026 2001 2013 1998 1989 200 400 600

Peers

Thomas M. Grogan
Stephan Dirnhofer Switzerland
Raymond R. Tubbs United States
Jeffrey Cossman United States
Izidore S. Lossos United States
Hans Tesch Germany
Stephan Dirnhofer Switzerland
Thomas M. Grogan
Citations per year, relative to Thomas M. Grogan Thomas M. Grogan (= 1×) peers Stephan Dirnhofer

Countries citing papers authored by Thomas M. Grogan

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Grogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Grogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Grogan more than expected).

Fields of papers citing papers by Thomas M. Grogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Grogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Grogan. The network helps show where Thomas M. Grogan may publish in the future.

Co-authorship network of co-authors of Thomas M. Grogan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Grogan. A scholar is included among the top collaborators of Thomas M. Grogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Grogan. Thomas M. Grogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Roger C., et al.. (2025). Blackbody radiation Zeeman shift in Rydberg atoms. Physical review. A. 111(6).
2.
Loftin, Isabell R., Stacey Stanislaw, Wenjun Zhang, et al.. (2010). The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays. Methods. 52(4). 287–300. 42 indexed citations
3.
Rimsza, Lisa M., Michael LeBlanc, Joseph M. Unger, et al.. (2008). Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood. 112(8). 3425–3433. 108 indexed citations
5.
Nitta, Hiroaki, Jiro Kishimoto, & Thomas M. Grogan. (2003). Application of Automated mRNA In Situ Hybridization for Formalin-fixed, Paraffin-embedded Mouse Skin Sections. Applied immunohistochemistry & molecular morphology. 11(2). 183–187. 23 indexed citations
6.
Rangel, Catherine S., et al.. (2003). Immunohistochemistry in Leukemias and Lymphomas. Humana Press eBooks. 55. 301–319. 2 indexed citations
7.
Nitta, Hiroaki, et al.. (2002). P1-07 Automated Colormetric Tyramide Signal Amplification In Situ Hybridization (TISH) Detection of Single HER-2/neu Oncogene Copies. ACTA HISTOCHEMICA ET CYTOCHEMICA. 35(3). 224. 1 indexed citations
8.
Fisher, Richard I., Thomas P. Miller, & Thomas M. Grogan. (1998). New REAL clinical entities.. PubMed. 4 Suppl 2. S5–12. 9 indexed citations
9.
Einspahr, Janine G., et al.. (1997). Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.. PubMed. 6(8). 583–7. 44 indexed citations
10.
Chan, John K.C., Peter M. Banks, M. L. Cleary, et al.. (1994). A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology. 25(6). 517–536. 62 indexed citations
11.
Nelson, Mark A., Janine G. Einspahr, Celia A. Balfour, et al.. (1994). Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Letters. 85(1). 23–29. 140 indexed citations
12.
Leith, Catherine P., et al.. (1994). The Presence of bcl-1 and bcl-2 Gene Rearrangements in Diffuse Small Cleaved-Cell Lymphoma. Diagnostic Molecular Pathology. 3(3). 178–183. 2 indexed citations
13.
Banks, Peter M., John K.C. Chan, M. L. Cleary, et al.. (1992). Mantle Cell Lymphoma A Proposal for Unification of Morphologic, Immunologic, and Molecular Data. The American Journal of Surgical Pathology. 16(7). 637–640. 374 indexed citations
14.
Leong, Stanley P. L., et al.. (1991). Selection of cytotoxic T lymphocytes against autologous human melanoma from lymph nodes with metastatic melanoma using repeatedin vitro sensitization. Clinical & Experimental Metastasis. 9(3). 301–317. 2 indexed citations
15.
Villar, Hugo V., et al.. (1991). Immunophenotyping in the management of gastric lymphoma. The American Journal of Surgery. 161(1). 171–176. 16 indexed citations
16.
Salmon, S. E., Thomas M. Grogan, Thomas P. Miller, R J Scheper, & William S. Dalton. (1989). Prediction of Doxorubicin Resistance In Vitro in Myeloma, Lymphoma, and Breast Cancer by P-Glycoprotein Staining. JNCI Journal of the National Cancer Institute. 81(9). 696–701. 178 indexed citations
17.
Ray, C. George, et al.. (1989). The Use of Intravenous Ribavirin To Treat Influenza Virus-Associated Acute Myocarditis. The Journal of Infectious Diseases. 159(5). 829–836. 55 indexed citations
18.
Lippman, Scott M., et al.. (1988). Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomas.. PubMed. 112(2). 128–32. 19 indexed citations
19.
Miller, TP, Scott M. Lippman, Catherine Spier, Donald J. Slymen, & Thomas M. Grogan. (1988). HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma.. Journal of Clinical Investigation. 82(1). 370–372. 82 indexed citations
20.
Scuderi, Philip, et al.. (1987). Recombinant Interferon-γ Stimulates the Production of Human Tumor Necrosis Factor In Vitro. Journal of Interferon Research. 7(2). 155–164. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026